Monthly Archives: July 2023

Alnylam Announces Partnership with Roche to Co-Develop and Co-Commercialize Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension in Patients with High Cardiovascular Risk

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it has entered into a strategic agreement with Roche to develop and commercialize zilebesiran, Alnylam’s investigational RNAi therapeutic for the treatment of hypertension, which is currently in Phase 2 of development. The partnership allows for a bold development plan with […]

Lee Health’s Dr. Paul DiGiorgi selected as president of the Florida Society of Thoracic and Cardiovascular Surgeons

Dr. Paul DiGiorgi Dr. Paul DiGiorgi Lee Health’s Dr. Paul DiGiorgi has been named the incoming president of the Florida Society of Thoracic and Cardiovascular Surgeons. Dr. DiGiorgi was previously secretary/treasurer. He will replace immediate past president Dr. Gregory J. England from Panama City Beach. As president, Dr. DiGiorgi will focus on continuing the Society’s […]

Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back

Pictured: Pfizer’s sign at its La Jolla campus/iStock, JHVEPhoto As the infectious diseases market expands, Pfizer, Gilead and GSK will climb to the top of the industry and emerge as the most dominant players in the space, according to data analytics and consultancy GlobalData. In an industry analysis posted Wednesday, GlobalData projected that the infectious […]

Moanalua Medical Center Recognized for Cardiovascular Care

HONOLULU — Kaiser Permanente Moanalua Medical Center has received American Heart Association Get With The Guidelines® and Mission: Lifeline® achievement awards for demonstrating a commitment to following up-to-date, research-based guidelines for the treatment of heart disease and stroke, ultimately leading to more lives saved, shorter recovery times, and fewer readmissions to the hospital. Every 40 […]

Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010–2019)

Dean SG, Ricotta EE, Fintzi J, Lai YL, Kadri SS, Olivier KN, et al. Mycobacterial testing Trends, United States, 2009–2015(1). Emerg Infect Dis. 2020;26(9):2243–6. Article  PubMed  PubMed Central  Google Scholar  Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of Nontuberculous Mycobacterial Lung Disease in a large U.S. Managed […]

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis

Key Points Question  What are the patterns of anticoagulant utilization and the anticoagulants associated with the lowest risk for venous thromboembolism (VTE) recurrence in patients with cancer in a clinical setting? Findings  In this comparative effectiveness study with 5100 adult patients, twice as many patients were prescribed direct oral anticoagulants (DOACs) as other classes, and […]

Adults with HIV can lower risk for cardiovascular disease with daily statin, study finds

July 24, 2023 2 min read Source/Disclosures Published by: Source: Grinspoon S, et al. Key REPRIEVE results and the utility of statins among people living with HIV: What have we learned? Presented at: International AIDS Society Conference on HIV Science; July 23-26, 2023; Brisbane, Australia. Disclosures: Grinspoon reports receiving consulting fees from Marathon Asset Management, […]

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran

Objectives General objective Measuring safety of the booster doses of AstraZeneca vaccine in people vaccinated with two doses of Sinopharm or Sputnik V vaccines in Iran. Specific objectives 1) To Estimate the incidence of different types of serious adverse events (SAEs) within 13 weeks in all enrolled vaccinated individuals after either the first or second […]

Research Reveals Blood Platelets Play Important Role in Kawasaki Disease

Newswise — LOS ANGELES (July 24, 2023) — Cedars-Sinai Guerin Children’s investigators have advanced our understanding of the role that blood platelets play in Kawasaki disease, a serious illness that primarily affects children younger than 5 years old and causes their blood vessels to swell. The findings, published in the peer-reviewed journal JCI Insight, may guide the […]

A network medicine approach to study comorbidities in heart failure with preserved ejection fraction

Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10:401–10. Article  PubMed  Google Scholar  Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14:591–602. Article  PubMed  Google Scholar  Mishra S, Kass DA. Cellular and molecular pathobiology […]